Plain-English translation of NCT06906627 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
IRIS-CKD is testing whether sending kidney screening tests to your home makes it easier for people with type 2 diabetes to get checked for kidney disease, compared to getting tested the traditional way at a lab. About half of participants will receive a home kit with simple finger-stick and urine tests to complete, while the other half will receive a standard lab order. The study will track whether home testing helps more people actually complete their kidney screening.
Many people with type 2 diabetes aren't getting the kidney screening tests they need to catch kidney disease early. Researchers want to find out if making testing more convenient by sending it home could help more patients get screened and protect their kidney health.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either receive a home test kit delivered to your door or a standard lab order through your doctor's office. The home kit includes instructions for a simple finger-stick blood test and/or a urine sample collection. You'll complete the screening over about 3 months and have one follow-up period. The study is designed to be convenient and only requires about 3 months of your participation.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States